XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues        
Revenues $ 1,967 $ 2,100 $ 3,885 $ 4,127
Expenses        
Selling, general and administrative 676 685 1,298 1,291
Research and development 127 115 254 227
Amortization of intangible assets 302 360 612 717
Goodwill impairments 83 0 83 469
Asset impairments, including loss on assets held for sale 6 47 14 195
Restructuring, integration, separation and IPO costs 35 9 48 21
Other expense, net 0 542 2 512
Total expenses 1,806 2,370 3,439 4,618
Operating income (loss) 161 (270) 446 (491)
Interest income 3 2 5 4
Interest expense (410) (364) (772) (732)
Gain (loss) on extinguishment of debt 113 (45) 113 (50)
Foreign exchange and other 4 7 (3) 8
Loss before income taxes (129) (670) (211) (1,261)
(Provision for) benefit from income taxes (10) 77 6 61
Net loss (139) (593) (205) (1,200)
Net income attributable to noncontrolling interest (6) (2) (9) (5)
Net loss attributable to Bausch Health Companies Inc. $ (145) $ (595) $ (214) $ (1,205)
Basic loss per share attributable to Bausch Health Companies Inc. (in usd per share) $ (0.40) $ (1.66) $ (0.59) $ (3.37)
Diluted loss per share attributable to Bausch Health Companies Inc. (in usd per share) $ (0.40) $ (1.66) $ (0.59) $ (3.37)
Basic weighted-average common shares (in shares) 362.2 359.1 361.5 358.0
Diluted weighted-average common shares (in shares) 362.2 359.1 361.5 358.0
Product sales        
Revenues        
Revenues $ 1,947 $ 2,076 $ 3,845 $ 4,079
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 570 604 1,113 1,168
Other revenues        
Revenues        
Revenues 20 24 40 48
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 7 $ 8 $ 15 $ 18